Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Excess processed foods and high trans fat intake correlate with lower sperm counts
Made in France
Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isnt serious enough for treatment, said David A Ricks, chair and CEO of Eli Lilly, in a statement
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for glycaemic control and, under the brand Zepbound, for chronic weight management
There is a temptation, when facing the kind of demand disruption that GLP-1 represents, to treat it as existential and respond with wholesale portfolio transformation, but that response carries its own risks
Like any treatment, however, they come with trade-offs and are not a one-size-fits-all solution
